HERSHEY, Pa. -- The Penn State Hershey Office of Technology Development will host the next installment of the Ideas in Innovation Series from noon to 1 p.m. on Wednesday, April 30 in the Hershey Center for Applied Research, adjacent to the Penn State Hershey campus. The latest session is titled “A Myriad of Changes.”
John Lopinski, partner at Hodgson Russ, LLP, will discuss the changes the United States Patent and Trademark Office is making to the examination of patent applications for personalized medicine and naturally occurring substances.
Lopinski holds a Ph.D. in molecular biology and provides regular advice to universities and start-up companies on developing intellectual property strategies that encompass technology in human and veterinary diagnostics and therapeutics.
He will discuss the recently released guidelines from the United States Patent and Trademark Office for patent examiners to follow when reviewing patent applications that cover diagnostic methods, including aspects of personalized medicine, and naturally occurring substances.
The guidelines extend beyond recent court rulings and into the realm of what the United States Patent and Trademark Office will consider “non-patentable subject matter.”
The session will demonstrate for those working in the life sciences the changes associated with the guidelines and provide suggestions for investigators designing research that can generate protectable subject matter.